(Q48690931)

14 February 2018

title

The star-allele nomenclature: retooling for translational genomics. (English)

1 reference

14 February 2018

1 reference

Robarge JD

1

1 reference

14 February 2018

Li L

2

1 reference

14 February 2018

Desta Z

3

1 reference

14 February 2018

Nguyen A

4

1 reference

14 February 2018

Flockhart DA

5

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 September 2007

1 reference

14 February 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

14 February 2018

volume

82

1 reference

14 February 2018

issue

3

1 reference

14 February 2018

page(s)

244-248

1 reference

14 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100284

exact match

0 references

cites work

Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100284

7 January 2021

Polymorphic hydroxylation of Debrisoquine in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100284

7 January 2021

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100284

7 January 2021

Suggestions for the nomenclature of human alleles: relevance to ecogenetics, pharmacogenetics and molecular epidemiology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100284

7 January 2021

Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100284

7 January 2021

A New Statistical Method for Haplotype Reconstruction from Population Data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100284

7 January 2021

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100284

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100284

1 reference

14 February 2018

Dimensions Publication ID

0 references

1 reference

14 February 2018